Krista Ferrari

Title: Innovations by Krista Ferrari in DNA Polymerase Technology

Introduction

Krista Ferrari is an accomplished inventor based in Dunstable, MA (US). She has made significant contributions to the field of molecular biology, particularly in the development of DNA polymerase variants. Her work has implications for various applications in genetic research and diagnostics.

Latest Patents

Krista holds a patent for "Taq DNA polymerase variants with increased reverse transcriptase activity." This invention involves engineering Taq DNA polymerase mutants that exhibit reverse transcriptase activity compared to the wild type polymerase. The engineered variants are characterized and selected through polymerase chain reactions, which are visualized via electrophoresis on agarose gels. Initial screenings are followed by probe-based qualitative, real-time PCR (qPCR) using a typical reverse transcription cycling protocol to detect specified ribonucleic acid (RNA) target sequences. These engineered variants can produce robust cDNA from RNA target substrates and amplify that cDNA under standard reaction conditions without the need for added reverse transcriptase enzymes.

Career Highlights

Krista Ferrari is currently employed at Abclonal Science, Inc., where she continues to innovate in the field of biotechnology. Her work has been pivotal in advancing the capabilities of DNA polymerases, which are essential tools in molecular biology.

Collaborations

Krista collaborates with notable colleagues, including Zhenyu Zhu and Dapeng Sun. Their combined expertise enhances the research and development efforts at Abclonal Science, Inc.

Conclusion

Krista Ferrari's contributions to DNA polymerase technology exemplify the impact of innovative research in molecular biology. Her patented work not only advances scientific understanding but also provides practical tools for researchers in the field.